The study found that the rate of Covid19 infection was reduced from 51% of unvaccinated organ transplant patients to 19% of patients who received one dose of the vaccine and to 0.36% of patients who received two doses. of the vaccine.
According to a new study, vaccination against SARS-CoV-2 greatly reduces the risk of advanced infection and death in adult organ transplant recipients due to Covid19. The results of the study were published in the journal “Transplant”, the official journal of the Transplant Society and the International Liver Transplant Society. The magazine is published by Wolters Kluwer in the Lippincott portfolio.